NT_1170x120_1-11-18

John Parker

HDA’s statement on Inspector General’s DEA report

HDA’s statement on Inspector General’s DEA report

ARLINGTON, Va. — In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement last week: “Today’s

HDA issues statement on Inspector General’s DEA report

HDA issues statement on Inspector General’s DEA report

ARLINGTON, Va. —  In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement. “Today’s report by the

HDMA lauds FDA drug tracing guidelines

WASHINGTON — The Healthcare Distribution Management Association (HDMA) is praising the Food and Drug Administration for its flexibility pertaining to new product tracing rules, specifically on the FDA’s recently released guidance titled “Product Tracing Requirements — Compliance Policy.” The association had sent letters to the regulatory agency in November and then again last month in